BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33864956)

  • 41. [Expression of PD-1, TIM-3, LAG-3 and BTLA in diffuse large B-cell lymphoma and its effect on prognosis].
    Liu XY; Yuan XL; Ma RJ; Xu H; Yang SW; Nie L; Zhang L; Hu AX; Li Z; Zhu ZM
    Zhonghua Yi Xue Za Zhi; 2020 Sep; 100(36):2846-2853. PubMed ID: 32988145
    [No Abstract]   [Full Text] [Related]  

  • 42. Adverse prognostic impact of regulatory T-cells in testicular diffuse large B-cell lymphoma.
    Pollari M; Pellinen T; Karjalainen-Lindsberg ML; Kellokumpu-Lehtinen PL; Leivonen SK; Leppä S
    Eur J Haematol; 2020 Dec; 105(6):712-721. PubMed ID: 32632935
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The immune contexture of primary central nervous system diffuse large B cell lymphoma associates with patient survival and specific cell signaling.
    Alame M; Cornillot E; Cacheux V; Rigau V; Costes-Martineau V; Lacheretz-Szablewski V; Colinge J
    Theranostics; 2021; 11(8):3565-3579. PubMed ID: 33664848
    [No Abstract]   [Full Text] [Related]  

  • 44. Role of LAP
    Zhong W; Jiang ZY; Zhang L; Huang JH; Wang SJ; Liao C; Cai B; Chen LS; Zhang S; Guo Y; Cao YF; Gao F
    World J Gastroenterol; 2017 Jan; 23(3):455-463. PubMed ID: 28210081
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implication of immune cell signature of tumor microenvironment in diffuse large B-cell lymphoma.
    Yu H; Fu D; Xu PP; Cheng S; Wang L; Zhang YZ; Zhao WL
    Hematol Oncol; 2021 Dec; 39(5):616-624. PubMed ID: 34331367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ratio of Immune Response to Tumor Burden Predicts Survival Via Regulating Functions of Lymphocytes and Monocytes in Diffuse Large B-Cell Lymphoma.
    Ji H; Niu X; Yin L; Wang Y; Huang L; Xuan Q; Li L; Zhang H; Li J; Yang Y; An W; Zhang Q
    Cell Physiol Biochem; 2018; 45(3):951-961. PubMed ID: 29428948
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune Cell Landscape in Gastric Cancer.
    Yang Y; He W; Wang ZR; Wang YJ; Li LL; Lu JZ; Tao Y; Zhang J; Fu SJ; Wang ZP; Liu SH
    Biomed Res Int; 2021; 2021():1930706. PubMed ID: 33575321
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tim-1 blockade with RMT1-10 increases T regulatory cells and prolongs the survival of high-risk corneal allografts in mice.
    Tan X; Jie Y; Zhang Y; Qin Y; Xu Q; Pan Z
    Exp Eye Res; 2014 May; 122():86-93. PubMed ID: 24613782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic Impact of Tumor Microenvironment in Diffuse Large B-Cell Lymphoma Uniformly Treated With R-CHOP Chemotherapy.
    Gomez-Gelvez JC; Salama ME; Perkins SL; Leavitt M; Inamdar KV
    Am J Clin Pathol; 2016 Apr; 145(4):514-23. PubMed ID: 27124945
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oligoclonal T Cells Transiently Expand and Express Tim-3 and PD-1 Following Anti-CD19 CAR T Cell Therapy: A Case Report.
    Funk CR; Petersen CT; Jagirdar N; Ravindranathan S; Jaye DL; Flowers CR; Langston A; Waller EK
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30572564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FoxP3
    Saleh R; Elkord E
    Cancer Lett; 2020 Oct; 490():174-185. PubMed ID: 32721551
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function.
    Kim HR; Park HJ; Son J; Lee JG; Chung KY; Cho NH; Shim HS; Park S; Kim G; In Yoon H; Kim HG; Jung YW; Cho BC; Park SY; Rha SY; Ha SJ
    J Immunother Cancer; 2019 Dec; 7(1):339. PubMed ID: 31801611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
    Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
    Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survival.
    Chao C; Xu L; Silverberg MJ; Martínez-Maza O; Chen LH; Castor B; Abrams DI; Zha HD; Haque R; Said J
    AIDS; 2015 Sep; 29(15):1943-51. PubMed ID: 26355571
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis and Investigation of Bioinformatics and Epigenetics Reveal the Underlying Mechanisms by which FLOT2 Modulates the Progression of Diffuse Large B-cell Lymphoma.
    Zhang Y; Chen Y; Guo Q; Zhang Y; Liu A
    Discov Med; 2024 Mar; 36(182):621-631. PubMed ID: 38531803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancer.
    Fan K; Yang C; Fan Z; Huang Q; Zhang Y; Cheng H; Jin K; Lu Y; Wang Z; Luo G; Yu X; Liu C
    Cancer Lett; 2018 Apr; 418():167-175. PubMed ID: 29337110
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic Impact of Peripheral Blood T-Cell Subsets at the Time of Diagnosis on Survival in Patients with Diffuse Large B-Cell Lymphoma.
    Shin HJ; Kim DY; Chung J; Shin KH; Lee H
    Acta Haematol; 2021; 144(4):427-437. PubMed ID: 33271543
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tim-3 and its role in regulating anti-tumor immunity.
    Das M; Zhu C; Kuchroo VK
    Immunol Rev; 2017 Mar; 276(1):97-111. PubMed ID: 28258697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The number of tumour-infiltrating TIA-1+ cytotoxic T cells but not FOXP3+ regulatory T cells predicts outcome in diffuse large B-cell lymphoma.
    Hasselblom S; Sigurdadottir M; Hansson U; Nilsson-Ehle H; Ridell B; Andersson PO
    Br J Haematol; 2007 May; 137(4):364-73. PubMed ID: 17456059
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tim3
    Sun H; Gao W; Pan W; Zhang Q; Wang G; Feng D; Geng X; Yan X; Li S
    Inflammation; 2017 Aug; 40(4):1342-1350. PubMed ID: 28478516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.